Promis Reports No ARIA-E in PMN310 Alzheimer’s Trial Interim Data

Data ReadoutnegativePMN310Negative

AI Analysis

Summary

Promis reported interim data from the PMN310 Alzheimer's trial showing no ARIA-E (amyloid-related imaging abnormalities with edema), indicating a favorable safety profile for the investigational treatment.

Clinical Trial Data

Outcome Details

No amyloid-related imaging abnormalities with edema (ARIA-E) observed in interim data

Importance:5/10

Sentiment:

-0.60

Alzheimer'sclinical_trialsafety_datainterim_data

Related Companies

$PMN

Read the original article

Published by yahoo_finance on July 28, 2026 6:04 PM

Read Original